+5.6%
CVS vs BBIO
+26.8%
-21.3%
-26.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -12.5% | +5.2% | -17.7% | -12.3% |
| 7D | -11.1% | +10.0% | -21.1% | -10.9% |
| 30D | -7.4% | +17.8% | -25.2% | -7.3% |
| 3M | -22.9% | -5.1% | -17.8% | -22.9% |
| 6M | -1.2% | +12.9% | -14.1% | -1.2% |
| YTD | +3.9% | +1.8% | +2.0% | +4.1% |
| 1Y | +5.6% | +26.9% | -21.4% | +0.5% |
| All | +5.6% | +26.8% | -21.3% | +0.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling